Variant Bio
Latest round
- Series A
Last raised
- May 2020
Total raised
- $33M
Investors
- 2
About Variant Bio
Based in the US, Variant Bio Inc.Variant Bio Inc. focuses on developing therapies informed by human genetics. Founded in 2018 in New York, US, it has undergone three significant deals.00 mn.Variant Bio's primary focus is on developing life-saving therapies through the study of human genetics, particularly by analyzing genes from individuals exhibiting exceptional health-related traits. By leveraging insights from human genetics, the company aims to identify the molecular basis of diseases, thereby improving the success rates of clinical trials significantly. The firm operates at the intersection of genetics, drug discovery, molecular biology, anthropology, and ethics, ensuring a comprehensive approach to drug development. Their collaborative model involves partnering with diverse communities globally, demonstrating a commitment to ethical research practices while benefiting those communities involved.Variant Bio's revenue structure is predicated on partnerships and collaborations in the biotechnology and pharmaceutical sectors. The company engages in B2B transactions, primarily collaborating with academic institutions and healthcare providers to facilitate genomic research initiatives and therapeutic development. Revenue is generated through a combination of research grants, partnership agreements, and milestone payments associated with successful clinical advancements of their therapeutic candidates.In January 2025, Variant Bio Inc. The company is actively working on the design and launch of new therapeutic products, with specific release dates to be determined.
Who invested in Variant Bio
2 investors across 2 rounds
See all investors in Variant Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Variant Bio
Who invested in Variant Bio?
Variant Bio has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Variant Bio raised?
Variant Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Variant Bio last raise money?
Variant Bio's most recent round on record is a Series A, in May 2020.
What does Variant Bio do?
Based in the US, Variant Bio Inc.
Where is Variant Bio headquartered?
Variant Bio is headquartered in New York, US.
Which VCs invest in companies like Variant Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Variant Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Variant Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.